Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

Annals of the Rheumatic Diseases

Volumn 61, Issue 10, 2002, Pages 889-894

  Peltomaa, Ritva ^a   Paimela, L ^b   Kautiainen, H ^c   Leirisalo Repo, M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ORTON Invalid Foundation   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PODOPHYLLOTOXIN; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEPSIS; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CAUSE OF DEATH; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036785352     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.10.889     Document Type: Article

References (45)

1. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheum 1995;13:149-53.
2. Pincus T, Brooks RH, Callahan JF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count. Ann Intern Med 1994;120:26-34.
3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
4. Gabriel SE, Crowson CS, O'Fallon WM. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol 1999;26:2529-33.
5. Kvalvik AG, Jones MA, Symmons DPM. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 2000;29:29-37.
6. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow-up. J Rheumatol 1984;11:158-61.
7. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
8. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58:11-14.
9. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
10. Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl 1996;44:13-22.
11. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98.
12. Kroot EJA, van Leeuwen MA, van Rijswik MH, Van't Hof MA, van de Putte LBA, van Riel PLCM. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-8.
13. Benn R, Wood PH. Mortality in rheumatoid arthritis. British Journal of Preventive Medicine 1972;26:60.
14. Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74.
15. Erhardt CC, Mumford PA, Venables PJW, Maini RN. Factors predicting a poor Life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13.
16. Mutru O, Laakso M, Isomäki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. BMJ 1985;290:1797-9.
17. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) 1999;38:499-503.
18. Jones M, Symmons D, Finn J, Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheumatol 1996;35:738-45.
19. Landewe RBM, van den Borne BEEM, Breedveld FC, Dijkmans BAC. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity [letter]. Lancet 2000;355:1616-17.
20. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol 1995;22:2214-17.
21. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage cardiovascular system? Postgrad Med J 1994;70:863-70.
22. Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:1755-6.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 1990;17(suppl 22):12-15.
25. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
26. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977;18:481-91.
27. Armitage P, Berry G. In: Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific, 1994
28. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21.
29. Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982;11:81-6.
30. Jacobsson LTH, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, et al. Rheumatoid arthritis and mortality. Arthritis Rheum 1993;36:1045-53.
31. Riise T, Jacobsen BK, Gran JT, Haga H-J, Arnesen E. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol 2001;20:123-7.
32. Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193-202.
33. Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998;25:1072-7.
34. Isomäki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol 1992;21 (suppl 95):3-8.
35. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman A. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990;49:363-9.
36. Corbett M, Dalton S, Young A, Silman A, Shipley M. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Br J Rheumatol 1993;32:717-23
37. Sokka T, Möftönen T, Hannonen P. Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol 1999;28:282-7.
38. Leigh JP, Fries JF. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 1991;18:1307-12.
39. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificates. Scand J Rheumatol 1981;10:301-6.
40. Söderlin MK, Nieminen P, Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 1998;25:1895-9.
41. Coste J, Jougla E. Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol 1994;23:545-52
42. Laakso M, Isomäki H, Mutru O, Koota K. Death certificate and mortality in rheumatoid arthritis. Scand J Rheumatol 1986;15:129-33.
43. Koota K, Isomäki H, Mutru P. Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol 1977;6:241-4.
44. Laakso M, Mutru O, Isomäki H, Koota K. Cancer mortality in patients with rheumatoid arthritis. J Rheumatol 1986;13:522-6.
45. Heliövaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.